Skip to main content

J&J Starts Vaccine Trials On Humans

American Pharmaceutical giant, Johnson & Johnson (J&J), announced yesterday that it was starting safe human trials with its COVID-19 vaccine after its study on monkeys showed that its best-performing vaccine candidate offered strong protection in a single dose.

A published study in the journal, Nature, stated that during the conduct of the trials, when exposed to the virus, 6 out of 6 animals who were given the experimental vaccine were completely protected from lung disease. Also, 5 out of the 6 animals were protected from infection as measured by the presence of the virus in nasal swaps.

The Chief Scientific Officer of J&J, Dr. Paul Stoffels, in a telephone conversation with Reuters said, ‘’This gives us confidence that we can test a single-shot vaccine in this epidemic and learn whether it has a protective effect in humans.”

J&J said that it had started early-stage human trials in the United States and Belgium and would test the experimental vaccine on more than 1,000 healthy adults that are aged between 18 to 55 years, as well as adults who are 65 years and above.

It was also revealed that the United States Government is supporting J&J’s vaccine development with $456 million in funding as part of its massive financial commitment to help intensify development and production of a vaccine to stop the pandemic, which has infected over 16.7 million people and killed more than 660,000 people.

Stoffels said that initial tests of this vaccine on other diseases discovered that a second shot significantly increases protection. But in a pandemic, a single-shot vaccine has a significant advantage, sidestepping a lot of the logistical issues involved in getting people to come back for their second dose.

He said that data shows that the Coronavirus experimental vaccine generated a strong antibody response and provided protection with only a single dose.

The company wants to take up the question of one or two doses in its first phase of the trial.

Stoffels pointed out that depending on the result that is gotten, J&J plans to start large scale phase 3 testing with a single dose regimen in the second half of September. The company hopes to start a parallel phase 3 study testing of a 2 dose regimen of the vaccine around the same time.

The white house coronavirus task force coordinator, Deborah Birx, during an interview with Fox News said, “The Johnson & Johnson vaccine is exciting because it’s a single dose. Having one dose show protection in monkeys like the other vaccines have shown with two doses does shorten the time period for development because your readout becomes 30 days quicker.”

J&J’s technology is really based on the human adenovirus, a type of common cold virus, it’s an approach that is perhaps best known for its use in an Ebola vaccine.

Comments

Popular posts from this blog

EndSARS: Protesters In New York Want SARS Operatives Sacked

 Hundreds of young anti-SARS protesters on Sunday stormed the Nigeria House in New York demanding transparency in the disbandment of the police unit back home. The protesters said operatives of the Special Anti-Robbery Squad found wanting should be sacked and not redeployed. Among them was Stephen “Papi” Ojo, the artist, model, and choreographer who stole the show as the ‘blue-guy’ in Beyoncé’s “Already” music video. The protest started shortly after the Inspector-General of Police, Mohammed Adamu, announced the dissolution of the Federal Special Anti-Robbery Squad. Adamu also announced plans for a new arrangement to address anticipated policing gaps following the disbandment, and the constitution of an investigative team to probe the alleged cases of rights violations, among others. But the protesters, who bore placards with different inscriptions including, “We no want audio ban”, said they were not buying it. They argued that previous commitments announced by the force to change...

Biden Announces Purchase Of 200M Vaccine Doses

  President Joe Biden announced a series of measures on Tuesday aimed at ramping up coronavirus vaccine allocation and distribution, including the purchase of 200 million more vaccine doses and increased distribution to states by millions of doses next week. With those additional doses, Biden said there would be enough to fully vaccinate 300 million Americans -- nearly the entire US population -- by the end of summer or early fall. He described efforts to combat Covid-19 as a "wartime undertaking." We now have a national strategy to beat Covid-19. It's comprehensive. It's based on science, not politics. It's based on truth, not denial, and it is detailed," he said. As part of the new efforts announced Tuesday, the US will buy 100 million more doses from Pfizer/BioNTech and 100 million more from Moderna -- the two-dose vaccines that have been granted emergency use authorization by the US Food and Drug Administration. Pfizer and Moderna are working to step up p...

Open grazing ban in South irreversible, Akeredolu replies Malami

  The Ondo State Governor, Rotimi Akeredolu, has tackled the Attorney General of the Federation and Minister of Justice, Mr Shehu Malami, for faulting the ban placed on open grazing in the Southern part of the country. The Southern Governors had at a meeting in Asaba last week banned open grazing and asked the President, Major General Muhammadu Buhari (retd.), to address the nation over the increasing rate of insecurity in the country. However, Malami who appeared as a guest on Channels Television on Wednesday faulted the ban, arguing that the governor had no right to do that. Akeredolu, who is the Chairman of Southern Governors’ Forum, spoke in a statement he personally signed on Thursday, titled, ‘ Our decision is irreversible and will be enforced ’. He asked the AGF to challenge the governor’s position on open grazing in court, adding that Malami’s comments were “ unfortunate and wicked ”. Part of the statement read, “I have just read the press statement credited to the Attorney...